Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bazelon M., Paine R. S., Coeiw V. A., Hunt P., Houck J. C., Mahanand D. Reversal of hypotonia in infants with Down's syndrome by administration of 5-hydroxytryptophan. Lancet. 1967 May 27;1(7500):1130–1133. doi: 10.1016/s0140-6736(67)91708-4. [DOI] [PubMed] [Google Scholar]
- Bertaccini G. Tissue 5-hydroxytryptamine and urinary 5-hydroxyindoleacetic acid after partial or total removal of the gastro-intestinal tract in the rat. J Physiol. 1960 Sep;153(2):239–249. doi: 10.1113/jphysiol.1960.sp006532. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Doery J. C., Hirsh J., Garson O. M., de Gruchy G. C. Platelet-phosphohexokinase levels in Down's syndrome. Lancet. 1968 Oct 26;2(7574):894–895. doi: 10.1016/s0140-6736(68)91057-x. [DOI] [PubMed] [Google Scholar]
- HAVERBACK B. J., DAVIDSON J. D. Serotonin and the gastrointestinal tract. Gastroenterology. 1958 Dec;35(6):570–578. [PubMed] [Google Scholar]
- JEROME H., LEJEUNE J., TURPIN R. [Study of the urinary excretion of some tryptophan metabolites in mongoloid children]. C R Hebd Seances Acad Sci. 1960 Jul 18;251:474–476. [PubMed] [Google Scholar]
- JEROME H. [Abnormalities of tryptophan metabolism in mongolism]. 1962 Jan 2-Feb 26Bull Mem Soc Med Hop Paris. 113:168–172. [PubMed] [Google Scholar]
- Krajl M. A rapid microfluorimetric determination of monoamine oxidase. Biochem Pharmacol. 1965 Nov;14(11):1684–1686. doi: 10.1016/0006-2952(65)90025-0. [DOI] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- O'BRIEN D., GROSHEK A. The abnormality of tryptophane metabolism in children with mongolism. Arch Dis Child. 1962 Feb;37:17–20. doi: 10.1136/adc.37.191.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ROSNER F., ONG B. H., PAINE R. S., MAHANAND D. BLOOD-SEROTONIN ACTIVITY IN TRISOMIC AND TRANSLOCATION DOWN'S SYNDROME. Lancet. 1965 Jun 5;1(7397):1191–1193. doi: 10.1016/s0140-6736(65)92722-4. [DOI] [PubMed] [Google Scholar]
- Robinson D. S., Lovenberg W., Keiser H., Sjoerdsma A. Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo. Biochem Pharmacol. 1968 Jan;17(1):109–119. doi: 10.1016/0006-2952(68)90163-9. [DOI] [PubMed] [Google Scholar]
- Rosner F., Ong B. H., Paine R. S., Mahanand D. Biochemical differentiation of trisomic Down's syndrome (mongolism) from that due to translocation. N Engl J Med. 1965 Dec 16;273(25):1356–1361. doi: 10.1056/NEJM196512162732503. [DOI] [PubMed] [Google Scholar]
- SADLER J. R., NOVICK A. THE PROPERTIES OF REPRESSOR AND THE KINETICS OF ITS ACTION. J Mol Biol. 1965 Jun;12:305–327. doi: 10.1016/s0022-2836(65)80255-8. [DOI] [PubMed] [Google Scholar]
- Tissot R., Guggisberg M., Constantinidis J., Bettschart W. Excrétion urinaire de l'acide 5-hydroxyindolacétique, de l'acide vanillomandélique et de l'acide xanthurénique chez 18 mongoliens. Pathol Biol. 1966 Mar;14(5):312–316. [PubMed] [Google Scholar]
- Tu J. B., Zellweger H. Blood-serotonin deficiency in Down's syndrome. Lancet. 1965 Oct 9;2(7415):715–716. doi: 10.1016/s0140-6736(65)90454-x. [DOI] [PubMed] [Google Scholar]
- VAZQUEZ H. J., PIAN E. B., HOJMAN N. [The use of nialamide in mongoloid children. (Preliminary report)]. Sem Med. 1961 Apr 20;118:803–807. [PubMed] [Google Scholar]